Aclaris Therapeutics ACRS Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$19.82M-0.1% | -$19.8M-35.5% | -$14.61M+5.3% | -$15.43M-2.3% | -$15.09M+84.4% | ||
| $102K0.0% | $102K-7.3% | $110K-3.5% | $114K-10.9% | $128K-10.5% | ||
| $3.2M+9.3% | $2.93M+2.3% | $2.86M-6.6% | $3.06M-13.4% | $3.54M+23.6% | ||
| $1.51M-61.8% | $3.96M+951% | $377K-84.6% | $2.44M+46.8% | $1.66M+156% | ||
| -$3.03M— | —— | —— | —— | -$11.04M— | ||
| -$854K+34.6% | -$1.31M-82.7% | -$715K+25.7% | -$962K-15.5% | -$833K-114% | ||
| —— | $400K+300% | $100K-93.3% | $1.5M+400% | $300K— | ||
| -$18.15M-38.2% | -$13.13M-20.1% | -$10.93M-9.4% | -$9.99M+23.5% | -$13.06M-46.1% | ||
| $13K-45.8% | $24K+4.3% | $23K+9.5% | $21K-51.2% | $43K— | ||
| -$30.93M-398% | $10.37M-25.0% | $13.83M+174% | $5.05M-73.6% | $19.12M+122% | ||
| $151K— | —— | —— | —— | —— | ||
| $250K+54.3% | $162K— | $0-100% | $9K-96.7% | $275K-17.4% | ||
| $57.78M+2,380% | -$2.53M+16.8% | -$3.04M-33,722% | -$9K+96.7% | -$275K-100% | ||
| $8.7M+264% | -$5.3M— | —— | —— | $5.79M+125% | ||
| —— | $400K+300% | $100K-93.3% | $1.5M+400% | $300K— | ||
| —— | —— | —— | —— | —— | ||
| -$742K— | —— | —— | —— | -$8.28M-197% | ||
| -$3.03M— | —— | —— | —— | -$11.04M— | ||
| —— | —— | —— | —— | $833K— | ||
| $57.88M— | —— | —— | —— | —— | ||
| $60K+567% | $9K— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$854K+34.6% | -$1.31M-82.7% | -$715K+25.7% | -$962K-15.5% | -$833K-114% | ||
| -$18.16M-38.1% | -$13.16M-20.1% | -$10.96M-9.4% | -$10.01M+23.6% | -$13.1M-46.6% | ||
| -$18.16M-38.1% | -$13.16M-20.1% | -$10.96M-9.4% | -$10.01M+23.6% | -$13.1M-46.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Aclaris Therapeutics generate?
- Aclaris Therapeutics (ACRS) generated -$52.2M in operating cash flow over the trailing twelve months.
- What is Aclaris Therapeutics's free cash flow?
- After $81.0K of capital expenditures, Aclaris Therapeutics's free cash flow was -$52.3M over the trailing twelve months, up 5.4% year over year.
- Where does Aclaris Therapeutics's cash flow data come from?
- Every line is extracted from Aclaris Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
